Literature DB >> 19026262

Does interpersonal loss preceding panic disorder onset moderate response to psychotherapy? An exploratory study.

Ellen Tobey Klass1, Barbara L Milrod, Andrew C Leon, Sarah J Kay, Michael Schwalberg, Chunshan Li, John C Markowitz.   

Abstract

BACKGROUND: Little research has addressed moderators of treatment outcome for anxiety disorders, and none has considered interpersonal loss as a predictor of outcome.
PURPOSE: To examine the effect of interpersonal loss events within the 6 weeks preceding panic disorder onset as a moderator of outcome in a randomized controlled trial of Panic-Focused Psychodynamic Therapy (PFPP) and Applied Relaxation Therapy (ART). Researchers hypothesized that such loss events would predict better outcome in PFPP but would not affect ART outcome.
METHOD: Forty-nine subjects with panic disorder were randomly assigned to a 12-week course of PFPP or ART. Independent raters blinded to treatment condition and study hypotheses rated subjects on the Panic Disorder Severity Scale (PDSS) and Sheehan Disability Scale. Exploratory analyses assessed between-group effect size for PFPP and ART following standard moderator analytic procedures. The trial was conducted between February 2000 and January 2005.
RESULTS: Three quarters of subjects reported a narrowly defined interpersonal loss (LOSS) in the 6 weeks preceding panic disorder onset. These subjects had a mean (SD) duration of panic disorder of 8.2 (9.5) years. PFPP was more efficacious than ART, but LOSS did not moderate PFPP outcome. An unexpected finding was that LOSS moderated ART outcome: subjects without LOSS showed no response to ART (PDSS mean (SD) change score = 0.00 [2.90]), whereas LOSS had a pre-post mean (SD) change score of 4.29 (5.60). Neither examination of potential confounding variables nor sensitivity analyses of assumptions regarding attrition altered these findings.
CONCLUSIONS: Interpersonal loss events preceding onset of panic disorder were more common even than in prior studies. These losses moderated outcome in ART, a therapy that does not focus on such losses. Implications and the need for future research before incorporating these findings into clinical practice are discussed. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00128388. ©Copyright 2009 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 19026262      PMCID: PMC3640856          DOI: 10.4088/jcp.08m04248

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  18 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

2.  Assessing impairment in patients with panic disorder: the Sheehan Disability Scale.

Authors:  A C Leon; M K Shear; L Portera; G L Klerman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-03       Impact factor: 4.328

3.  Recent life events and panic disorder.

Authors:  C Faravelli; S Pallanti
Journal:  Am J Psychiatry       Date:  1989-05       Impact factor: 18.112

4.  Panic onset and major events in the lives of agoraphobics: a test of contiguity.

Authors:  C A Pollard; H J Pollard; K J Corn
Journal:  J Abnorm Psychol       Date:  1989-08

5.  Eleventh Emil A. Gutheil memorial conference. Therapeutic factors in psychotherapy.

Authors:  J D Frank
Journal:  Am J Psychother       Date:  1971-07

6.  Emotional processing of fear: exposure to corrective information.

Authors:  E B Foa; M J Kozak
Journal:  Psychol Bull       Date:  1986-01       Impact factor: 17.737

7.  Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder.

Authors:  G G Manfro; M W Otto; E T McArdle; J J Worthington; J F Rosenbaum; M H Pollack
Journal:  J Affect Disord       Date:  1996-11-25       Impact factor: 4.839

8.  Multicenter collaborative panic disorder severity scale.

Authors:  M K Shear; T A Brown; D H Barlow; R Money; D E Sholomskas; S W Woods; J M Gorman; L A Papp
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

9.  Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder.

Authors:  Borwin Bandelow; Corinna Späth; Gabriel Alvarez Tichauer; Andreas Broocks; Göran Hajak; Eckart Rüther
Journal:  Compr Psychiatry       Date:  2002 Jul-Aug       Impact factor: 3.735

10.  Posttraumatic stress disorder in the National Comorbidity Survey.

Authors:  R C Kessler; A Sonnega; E Bromet; M Hughes; C B Nelson
Journal:  Arch Gen Psychiatry       Date:  1995-12
View more
  5 in total

Review 1.  Critical review of outcome research on interpersonal psychotherapy for anxiety disorders.

Authors:  John C Markowitz; Joshua Lipsitz; Barbara L Milrod
Journal:  Depress Anxiety       Date:  2014-02-03       Impact factor: 6.505

2.  Prediction and moderation of improvement in cognitive-behavioral and psychodynamic psychotherapy for panic disorder.

Authors:  Dianne L Chambless; Barbara Milrod; Eliora Porter; Robert Gallop; Kevin S McCarthy; Elizabeth Graf; Marie Rudden; Brian A Sharpless; Jacques P Barber
Journal:  J Consult Clin Psychol       Date:  2017-06-26

3.  Catastrophic Appraisal and Perceived Control as Moderators of Treatment Response in Panic Disorder.

Authors:  Alicia E Meuret; Stefan G Hofmann; David Rosenfield
Journal:  Int J Cogn Ther       Date:  2010-09-01

4.  In-session emotional expression predicts symptomatic and panic-specific reflective functioning improvements in panic-focused psychodynamic psychotherapy.

Authors:  John R Keefe; Zeeshan M Huque; Robert J DeRubeis; Jacques P Barber; Barbara L Milrod; Dianne L Chambless
Journal:  Psychotherapy (Chic)       Date:  2019-03-14

Review 5.  Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Authors:  Alessandro Pompoli; Toshi A Furukawa; Hissei Imai; Aran Tajika; Orestis Efthimiou; Georgia Salanti
Journal:  Cochrane Database Syst Rev       Date:  2016-04-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.